• SGI-1027 and Everolimus Synergy: Lysosomal Permeability in R

  2026-06-02

  This study uncovers the synergistic effect of SGI-1027 and everolimus in inducing apoptosis and GSDME-dependent pyroptosis in renal cell carcinoma by triggering lysosomal membrane permeability. The findings offer new mechanistic insights and therapeutic strategies to overcome drug resistance in advanced RCC.

• Gramine: Mechanistic Leverage for Translational Ferroptosis

  2026-06-02

  Explore the transformative role of Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) as a precision ferroptosis inducer in aggressive breast cancer models. This article unpacks the CUL3–MTDH axis, offers detailed protocol guidance, situates Gramine in the competitive research landscape, and charts a translational roadmap for next-generation cancer biology.

• CD28-ARS2 Axis Drives PKM Splicing, Enhancing CD8+ T Cell Me

  2026-06-01

  The referenced study uncovers a novel CD28-ARS2 signaling axis in CD8+ T cells that regulates alternative splicing of pyruvate kinase M (PKM), promoting metabolic flexibility and antitumor immunity. These findings clarify how post-transcriptional control fine-tunes T cell metabolism, with implications for immunometabolic research and assay development.

• CTDNEP1-NEP1R1 Regulation of ER Lipid Synthesis and Storage

  2026-06-01

  This study uncovers how CTD-nuclear envelope phosphatase 1 (CTDNEP1) differentially relies on its regulatory subunit NEP1R1 to control endoplasmic reticulum (ER) membrane synthesis versus lipid droplet biogenesis. The findings clarify the molecular determinants of ER lipid homeostasis and reveal distinct regulatory mechanisms for membrane expansion and lipid storage.

• Luminescent ATP Detection Assay Kit: Redefining Inflammation

  2026-05-31

  Explore how the Luminescent ATP Detection Assay Kit empowers high-sensitivity ATP quantification for inflammation and energy metabolism studies. This article uniquely connects firefly luciferase ATP assay technologies to advances in ulcerative colitis mechanistic research.

• StrR-like Regulators Enhance A40926 Production: New Insights

  2026-05-30

  This article examines a recent study demonstrating that heterologous expression of certain StrR-like regulatory genes can significantly enhance the biosynthesis of glycopeptide antibiotics, including A40926, in actinomycetes. The findings offer a new strategy for activating and boosting production of clinically relevant antibiotics and provide a framework for regulatory gene manipulation in antibiotic discovery.

• Validating Metabolite Regulation of TET2 Dioxygenase: Protoc

  2026-05-29

  This article examines a 2025 protocol that integrates biochemical assays and STD NMR spectroscopy to validate metabolite binding and regulatory effects on TET2 dioxygenase. The approach enables precise identification of both activators and inhibitors, offering a robust framework for studying the interplay between cellular metabolism and epigenetic enzyme activity.

• ILF3 Stabilizes SLC3A2 mRNA to Confer Ferroptosis Resistance

  2026-05-29

  This study identifies ILF3 as a key RNA-binding protein that elevates resistance to ferroptosis in colorectal cancer by stabilizing SLC3A2 mRNA, thereby promoting cystine uptake and glutathione synthesis. The findings highlight a mechanistic link between tumor inflammatory signaling, ILF3 regulation, and ferroptosis evasion, offering new therapeutic targets for overcoming drug resistance in cancer.

• CTDNEP1-NEP1R1 Complex: Differential Roles in ER Lipid Regul

  2026-05-28

  This study elucidates how the CTDNEP1-NEP1R1 complex differentially regulates ER membrane synthesis and lipid storage through selective stabilization and interaction mechanisms. The findings refine our understanding of lipid homeostasis, with implications for dissecting protein and lipid quality control in mammalian cells.

• CB-5083: Precision p97 Inhibition for Tumor Growth Suppressi

  2026-05-28

  CB-5083 empowers researchers to disrupt protein homeostasis and induce apoptosis in cancer models with exceptional selectivity. This article details applied workflows, advanced troubleshooting, and the latest insights bridging p97 inhibition with ER lipid regulation, setting a new benchmark for reproducible oncology research.

• Bafilomycin A1: Unlocking V-ATPase Function in Centrosomal R

  2026-05-27

  Explore Bafilomycin A1 as a selective V-ATPase inhibitor for advanced centrosomal and lysosomal function research. This article uniquely bridges ion transport inhibition with proteostasis and cell cycle regulation, offering fresh insights for cell biology and cancer research.

• NBC19: Advanced NLRP3 Inflammasome Inhibitor for Inflammatio

  2026-05-27

  NBC19 empowers researchers to dissect NLRP3 inflammasome signaling with nanomolar precision, offering robust IL-1β suppression under Nigericin and ATP stimulation. Its validated efficacy in THP1 models and actionable protocol guidance make it a go-to tool for translational inflammation and metastasis research.

• Aconitase Activity Colorimetric Assay Kit: Oxidative Stress

  2026-05-26

  Explore how the Aconitase Activity Colorimetric Assay Kit empowers precise quantification of mitochondrial aconitase activity as a biomarker of oxidative stress, with unique insights into metabolic flexibility and T cell immunometabolism. This article offers an advanced, evidence-based analysis distinct from prior reviews.

• MLN4924: NEDD8-Activating Enzyme Inhibitor for Cancer Resear

  2026-05-26

  MLN4924 empowers cancer biology researchers with precise, robust inhibition of the neddylation pathway, making it an essential tool for dissecting protein degradation mechanisms. This guide details optimized workflows, applied use-cases, and expert troubleshooting for maximizing the value of MLN4924 in advanced experimental settings.

• Optimizing Cell-Based Assays: Practical Scenarios with PR-61

  2026-05-25

  This authoritative guide addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how PR-619 (SKU A8212) delivers reproducible, data-driven solutions across ubiquitination pathway research. By leveraging scenario-based Q&A, the article highlights PR-619's unique technical profile and workflow advantages for biomedical researchers.

16577 records 1/1106 page Next 12345 下5页 Last page